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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S128Purpose: Currently, there is no disease-modifying OA drug (DMOAD). We
have conceived that a strategy that achieves cartilage repair as well as
delays or stops OA progression may provide a better therapeutic solution.
Here we attempted to identify a new DMOAD candidate effective for both
repairing cartilage by promoting chondrogenic differentiation and halting
OA progression by suppressing aberrant hypertrophy. Then, we tested its
efﬁcacy as a DMOAD by injecting intraarticularly into mouse OA model
both at the onset of the model (preventionmodel) and at 4 weeks after the
onset (repair model). We further investigated the mechanism of the drug
action using in vitro and in vivo assays to investigate its molecular target.
Methods: We recently discovered a small thienoindazole-derivative
compound TD-198946 (TD), enhancing chondrogenic differentiation
without promoting hypertrophy using an efﬁcient monitoring system
expressing green ﬂuorescent protein under the control of type II collagen
promoter fused with four repeats of a Sox9 enhancer (COL2-GFP). Chon-
drogenic differentiation was assessed by real-time RT-PCR for Col2a1,
aggrecan, and Col10a1, Toluidine blue and Alcian blue stainings, and
quantitative GAG assay in immature mesenchymal C3H10T1/2 cells or
cultures of mouse primary chondrocytes. We injected TD intraarticulaly,
either immediately (prevention model) or 4 weeks (repair model) after OA
model surgery inmice. Knee joints were harvested at 8weeks after surgery
to examine the effects of TD on OA cartilage phenotypes using histology
and OARSI scores. The downstream molecules were screened by a micro-
array analysis using C3H10T1/2 cells. The COL2 promoter activity was
determined using HuH-7 cells transfected with a luciferase-reporter gene
construct containing the COL2 promoter above, and the speciﬁc binding to
the identiﬁed region was veriﬁed by electrophoretic mobility shift assay
(EMSA) and chromatin immunoprecipitation (ChIP). For functional anal-
yses, we performed adenoviral overexpression of the gene or the small
interfering RNA in C3H10T1/2 cells and primary chondrocytes, and
compared the chondrogenic differentiation as described above with
respective empty-vector controls. Finally, we analyzed molecular target
protein levels in OA human and mouse cartilage samples by
immunohistochemistry.
Results: TD was conﬁrmed to enhance chondrogenic differentiation but
not to promote hypertrophy. Intraartiluar TD treatment increased
proteoglycan abundance and decelerated articular cartilage degeneration,
and resulted in signiﬁcantly lower OARSI scores compared with saline
treatment in both of prevention and repair model. Themicroarray proﬁling
revealed that Runx1 was most strongly induced by TD among a set of the
196 transcription-related genes associated with the Gene Ontology term,
Multicellular organismal development. Deletion, mutagenesis, and
tandem-repeat analyses of the luciferase assay identiﬁed the core
responsive element of Runx1 in the COL2 promoter to be between the -293
and -288 bp region containing a putative Runx-binding motif. EMSA and
ChIP assays conﬁrmed the speciﬁc binding of Runx1 to this region.
Chondrogenic differentiation of C3H10T1/2 cells was enhanced by the
Runx1 overexpression without promoting hypertrophy in primary chon-
drocytes, simulating of the effect of TD treatment. Gene-silencing of Runx1
suppressed TD's effects on chondrogenic differentiation. Finally, in OA
human and mouse cartilage samples, Runx1 expression was suppressed,
and type10 collagen expression was overexpressed. Intraartiluar TD
treatment restored these protein expressions in mouse OA model. Overall,
these data suggest that TD's action is mediated by Runx1 in articular
chondrocytes.
Conclusions: These preclinical ﬁndings provide proof-of-concept for the
use of a novel small compound TD to treat OA.
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PROPERTIES AND USEFULNESS OF AGGREGATES OF SYNOVIAL
MESENCHYMAL STEM CELLS AS A SOURCE FOR CARTILAGE
REGENERATION
S. Suzuki, I. Sekiya, K. Tsuji, T. Muneta. Tokyo Med. and Dental Univ., Tokyo,
Japan
Purpose: Transplantation of mesenchymal stem cells (MSCs) derived from
synovium is a promising therapy for cartilage regeneration. For clinicalapplication, improvement of handling operation, enhancement of chon-
drogenic potential, and increase of MSCs adhesion efﬁciency are needed to
achieve a more successful cartilage regeneration with limited number of
MSCs without scaffold. The use of aggregated MSCs may be one of the
solutions. Here, we investigated the handling, properties, and effectiveness
of aggregated MSCs for cartilage regeneration.
Methods: Synovial MSCs. Human synovium was harvested from donors
during ACL reconstruction surgery. Rabbit synovium was harvested from
the knee joint. After collagenase digestion, nucleated cells were
expanded, and colony forming cells were harvested. Preparation of
aggregates of MSCs. 2.5105 synovial MSCs suspended in 35ml of culture
medium were aggregated using the hanging drop technique. Microarray
analysis. Total RNA was extracted from human synovial MSCs in
a monolayer culture, aggregates of human synovial MSCs cultured for 3
days. In vitro chondrogenic differentiation assay. 2.5  105 human syno-
vial MSCs cultured as monolayer were pelleted by trypsinization and
centrifugation. The pellets or aggregate of human synovial MSCs cultured
for 3 days in hanging drop were cultured in 400ml chondrogenic medium.
The medium was changed every 3-4 days for 21 days. Transplantation of
aggregates of synovial MSCs in rabbits. Osteochondral defects (55 mm
wide, 1.5 mm deep) were created in the femoral groove, and 5, 10, 20, 40,
80 aggregates of autologous synovial MSCs were transplanted to the
defect. MSCs labeled with DiI and MSCs derived from GFP rabbit were
also used. The cartilage was evaluated at 1 day, 2, 4, 12 weeks after the
operation (n ¼ 5). Statistical analysis. To assess differences, the Kruskal-
Wallis test and the Steel test were used. A P value of < 0.05 was
considered statistically signiﬁcant.
Results: Aggregates of MSCs cultured for three days became visible,
approximately 1mm in diameter, and solid and durable by manipulation,
and most of the cells were viable. Microarray analysis revealed upregula-
tion of chondrogenesis-related genes (SOX5, -6, -9, and BMP2) and anti-
inﬂammatory (TSG-6, and STC-1) genes in aggregates of MSCs. In vitro
studies showed higher amounts of cartilage matrix synthesis in pellets
derived from aggregates of MSCs compared to pellets derived from MSCs
cultured in a monolayer. In in vivo studies in rabbits, aggregates of MSCs
could adhere promptly on the osteochondral defects by surface tension,
and stay without any loss. Transplantation of aggregates of MSCs at rela-
tively low density achieved successful cartilage regeneration. Contrary to
our expectation, transplantation of aggregates of MSCs at high density
failed to regenerate cartilage due to apoptosis and nutrient deprivation of
aggregates of MSCs.
Conclusions: Aggregated synovial MSCs were a useful source for cartilage
regeneration considering such factors as easy preparation, higher chon-
drogenic potential, and efﬁcient attachment.
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SURGICAL IMPACTION AND INTRA-ARTICULAR ENVIRONMENT
PREDETERMINE SURVIVAL AND METABOLISM OF OSTEOCHONDRAL
ALLOGRAFTS
S. Gitelis, R. Olewinski, S. Kirk, A. Hakimiyan, L. Rappoport, C. Pacione,
B. Cole, M. Wimmer, S. Chubinskaya. Rush Univ. Med. Ctr., Chicago, IL, USA
Purpose: The purpose of this continuing study was to compare cellular
responses of cartilage from fresh (FOC) and refrigerated osteochondral
(ROC) allografts under the conditions mimicking intra-articular environ-
ment combined with surgically relevant impaction.
Methods: FOCs were obtained within 24 hours of death through the Gift of
Hope Organ & Tissue Donor Network (IL); ROCs were received from Joint
Restoration Foundation after 14-28 days refrigerated storage. 8mm
osteochondral plugs harvested from twelve ROC and six FOC were tapped
10 times with a peak force of 75N mimicking surgical insertion technique.
Samples were then cultured for up to 14 days in media containing 10% fetal
bovine serum and divided into the following treatment groups: 1) Non-
impacted control (serum only), 2) impacted non-treated control (serum
only), 3) impacted IL-1b (0.1ng/ml), 4) impacted IL-1b (0.1ng/ml) + IL-6
(3ng/ml), 5) impacted IL-1b (10ng/ml). IL-6 soluble receptor (5ng/ml) was
added to all cultures containing IL-6. The concentration of cytokines was
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dral allograft surgeries and they were added to the culture media every 48
hours. Tissue andmedia samples were collected on days 0, 2, 7, and 14. Cell
viability (live/dead assay), apoptosis (TUNEL assay), histology with
Safranin O staining and modiﬁed Mankin score, proteoglycan (PG)
synthesis and content (normalized to wet weight) were used to analyze
cartilage survival and metabolism.
Results: At baseline (before impaction and treatment), no difference in
cell viability was found between FOC and ROC allografts. Impaction
decreased cell viability in ROC by 31% (superﬁcial layer, p<0.001) and 27%
(all layers, p¼0.0004) and had no effect on FOC. 2-weeks culture reduced
cell viability more in impacted ROC samples than in FOC samples , 64%
and 41% in the superﬁcial layer and 53% and 24% in all layers (p<0.001),
respectively in comparison to their corresponding non-impacted controls.
Cytokines did not induce further cell death. Impaction alone had no effect
on PG synthesis in both tissues. Addition of cytokines signiﬁcantly
decreased PG synthesis in ROC and FOC by a factor of 2 and 2.5,
respectively (cumulative values of all time points; p<0.01). No difference
was observed among treatment groups. Histology of ROC cartilage
depended on the graft storage time: <3weeks, ROC displayed normal
histological appearance at baseline; >3 weeks, it looked swollen with
a disrupted loose surface and reduced Safranin O staining. Impaction
alone had no signiﬁcant effect on ROC and FOC cartilage, but when
combined with high doses of IL-1 there was a depletion of Safranin O
staining by the end of culture.
Conclusions: Previously we showed that inﬂammatory cytokines were
not more detrimental to the survival and metabolism of ROC cartilage
in comparison to FOC. However, when combined with impaction the
effect was signiﬁcantly ampliﬁed causing more destruction to both
fresh and refrigerated tissues. Optimizing graft insertion technique and
control of intra-articular environment could warrant long-lasting
cartilage repair.
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CROSS-LINKED HYALURONIC ACID AS A SCAFFOLD FOR THE
TREATMENT OF CARTILAGE DEFECTS
C. Bauer. Danube Univ. Krems, Krems, Austria
Purpose: Tissue engineering is based on the use of various biomaterials
either cell-free or in combination with specialized cells for regeneration of
damaged or destroyed tissue. For cartilage regeneration biomaterials have
to feature good biocompatibility and biodegradability, allow proper cell
adhesion and promote the establishment and stabilization of a chon-
drocytic phenotype of cells. In this study we examined the effects of
a porous three-dimensional scaffold of cross-linked hyaluronic acid on the
gene expression and synthesis performance of chondrocytes.
Methods: Human articular cartilage was obtained from osteoarthritis
patients subjected to total knee arthrosplasty. After isolation of the
chondrocytes from cartilage tissue the cells were expanded and seeded
onto the scaffolds. This was followed by a three week cultivation period.
For estimation of the cell content, metabolic activity and DNA-content
within the scaffold were determined. The expression of chondrocyte-
speciﬁc genes as well as the synthesis of sulphated glycosaminoglycans
(sGAG) by embedded cells was analyzed in order to characterize the
synthesis performance and differentiation status of the cells.
Results: Cells showed homogenous distribution within the scaffold.
Although DNA quantiﬁcation indicated only partial loss of cells taking
place most probably in the course of media change due to matrix
degradation, the metabolic activity within the scaffolds decreased
dramatically during cultivation. This might be attributed to a stop in
cell proliferation combined with a switch of the cellular genetic
program from cell division to differentiation towards a chondrogenic
phenotype. Gene expression analyses of chondrogenic markers (e.g.
collagen 2) and analysis of sGAG synthesis substantiated this hypoth-
esis as both chondrocyte speciﬁc gene expression as well as sGAG
synthesis were increased and the differentiation index was clearly
improved.
Conclusions: These results suggest that the investigated material has
a chondroinductive effect on embedded cells.Ă
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NEW SYSTEM FOR NON-INVASIVE EXPLORATION OF SYNTHESIZED
COLLAGEN NETWORK INSIDE MESENCHYMAL STEM CELL
FUNCTIONALIZED BIOMATERIALS DEDICATED TO CLINICAL
IMPLANTATION IN CARTILAGE LESION
D. Dumas 1, C. Henrionnet 2, S. Hupont 1, E. Werkmeister 3, D. Hentsch 4, J.L.
Vonesh 4, P. Netter 2, J. Magdalou 2, J.F. Stoltz 2, P. Gillet, Sr. 2,
A. Pinzano 2. 1 Plate Forme Imagerie Cellulaire PTIBC-IBISA, UMR 7561 &
FR3209 CNRS-UHP, Vandoeuvre Les Nancy, France; 2UMR 7561 CNRS-Nancy
Univ., Vandoeuvre Les Nancy, France; 3MICPaL Facility - IFR 142 CNRS UMR
8161, LILLE,France; 4PlateFormeTechnologiqued'Imagerie, IGBMC, Illkirch, France
Purpose: One step of control and validation of collagen network inside
functionalized biomaterials is crucial before clinical implantation in tissue
engineering. Conventional optical techniques, like histology (Sirius red)
and ﬂuorescence (speciﬁc antibody), remained a reference for structural
characterization but their invasive character leads to development and
validation of non-invasive techniques. Combined with multiphoton ﬂuo-
rescence excitation, second harmonic generation (SHG) microscopy has
been demonstrated to be effective in numerous label-free tissue imaging
applications. Collagen could be detected as a harmonophore by F-SHG
index without an exogenous probe. The aim of this work was to test a new
system to evaluate at macroscopic scale the collagen network inside
mesenchymal stem cell (MSCs) functionalized biomaterials dedicated to
cartilage engineering. This system was performed from a two photon
excitation laser adapted to a optical macroscope (Patent CNRS - UHP).
Methods: Cartilaginous like implant was generated with human MSCs
issued from bone marrow seeded inside collagen sponge and cultured with
chondrogenic growth factor (TGF-b1 and ITS supplement) or not (ITS
supplement alone) during 28 days. Collagen network was studied by our
system at microscopic andmacroscopic scale and the quality of synthesized
matrix was conﬁrmed by gold standard histological techniques or immu-
nohistochemistry tovisualize type II collagen. To combinemultidimensional
ﬂuorescence data (time and spatial), we have considered a new multi-
modality imaging (SHG-TCSPC) based on Second Harmonic Generation
(SHG) method to detect especially collagen matrix and Time Correlated
Single Photon Counting (TCSPC) method to contrast signal (auto-ﬂuores-
cence background, SHG and immunolabeling staining). For both SHG-TCSPC
optical system (microscopy andmacroscopy), we introduced a F-SHG index
based on decay time response measured by TCSPC for respectively ﬂuo-
rescence (F) and Second Harmonic Generation (SHG) values.
Results: Inside our biomaterials, F-SHG index permitted to discriminate
signals of autoﬂuorescence, native collagen of sponge and synthesized
collagen by MSCs at the multi-scale (microscopy or macroscopy). This
index permitted to appreciate modiﬁcations of matrix collagen inside
sponge over time and to differentiate the quality of collagen network
between ITS and TGF-ß1 treatments. These observations were conﬁrmed
by histological and immunohistochemical analysis. Indeed, the quantity of
synthesized matrix and of detected type II collagen inside sponge was less
abundant with ITS in comparisonwith the chondrogenic condition TGF-ß1.
